Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Strahlentherapie und Onkologie
Published in: Strahlentherapie und Onkologie 6/2013

01-06-2013 | Literatur kommentiert

Niedermolekulares Heparin senkt Thromboserisiko bei chemotherapeutisch behandelten Tumorpatienten

Authors: S. Heller, PD Dr. M. Krause

Published in: Strahlentherapie und Onkologie | Issue 6/2013

Login to get access

Auszug

Agnelli G, George DJ, Kakkar AK et al (2012) Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med 366:601–609 …
Literature
1.
Borsig LL (2009) Heparin as an inhibitor of cancer progression. Prog Mol Biol Transl Sci 93:335–349CrossRef
2.
Agnelli G, George DJ, Kakkar AK et al (2012) Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med 366:601–609PubMedCrossRef
3.
Akl EA, Gunukula S, Barba M et al (2011) Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation. Cochrane Database Syst Rev CD006652
4.
Akl EA, Schünemann HJ (2012) Routine heparin for patients with cancer? One answer, more questions. N Engl J Med 366:661–662PubMedCrossRef
Metadata
Title
Niedermolekulares Heparin senkt Thromboserisiko bei chemotherapeutisch behandelten Tumorpatienten
Authors
S. Heller
PD Dr. M. Krause
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
Strahlentherapie und Onkologie / Issue 6/2013
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-013-0352-z

Other articles of this Issue 6/2013

Strahlentherapie und Onkologie 6/2013 Go to the issue

Original article

A validated scoring system to identify long-term survivors after radiotherapy for metastatic spinal cord compression

Literatur kommentiert

Bessere Mamma-MRT-Spezifität bei nichtmalignen Brustläsionen durch zusätzliche diffusionsgewichtete Sequenz bei kaum verlängerter Untersuchungsdauer

Original article

Effect of concurrent chemotherapy and hyperthermia on outcome of preoperative radiotherapy of high-risk soft tissue sarcomas

Original article

CyberKnife robotic image-guided stereotactic radiotherapy for oligometastic cancer

Literatur kommentiert

Bauchspeicheldrüse als Risikoorgan für die Induktion eines Diabetes mellitus bei Kindern nach Abdominalbestrahlung

Original article

Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapy